
Global Apheresis Market Trends, Applications, Analysis, Growth, and Forecast to 2027
-
2045
-
Upcoming
-
NA
-
PDF
-
find_in_page Our Research Methodology is based on the following main points:
- Data Collections and Interpretation
- Analysis
- Data Validation
- Final Projections and Conclusion
- notifications
- Request Covid Impact
- Table of Content
- List of Companies
- Inquiry Before Buying
- Request for Customization
-
-
MarketResearch.biz delivers in-depth insights on the global apheresis market in its upcoming report titled, “Global Apheresis Market Trends, Applications, Analysis, Growth, and Forecast to 2027”. The global apheresis market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global apheresis market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global apheresis market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global apheresis market report has been segmented on the basis of product, technology, application, and region.
Apheresis is a medical procedure which involves removing of blood from donor or patient to separate required blood components. Instead of direct collection into blood bags, a system tubing is connected to machine where a small centrifuge spins separates blood into basic components such as red blood cells, plasma, platelets, etc. After collection of desired product, the blood is safely returned to body with hydrating solution.
Increasing incidences of blood cancer among individuals is a key factor driving growth of the global apheresis market. In addition, increasing apheresis procedures in treatment of various diseases such as hematology, cardiovascular and autoimmune, rising demand of plasma from biopharmaceuticals industries are other factors expected to drive growth of the global apheresis market.
However, high cost of apheresis procedure is a major factor restraining growth of the global apheresis market. Additionally, lack of awareness among people, and serious complication to blood donor such as muscle cramping, tendency to bleed are other factors expected to hamper growth of the global apheresis market.
Technological advancement in apheresis devices is expected to present new opportunities for major market player in the global apheresis market over the forecast period.
North America market is a dominant player in the global apheresis market and accounts for largest market share in terms of revenue as compared to that of markets in other regions. This is attributed to well-developed healthcare infrastructure, and rise in number of patients suffering from blood cancer. Europe market accounts for the second largest revenue share contribution to the global apheresis market followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is projected to have the fastest growth in terms of revenue, owing to rising demand from biopharmaceuticals industries, and rise in governments initiatives for the improvement of healthcare facilities in countries in this region.
Market Segmentation:
Global apheresis market segmentation, by product:
- Apheresis Devices
- Apheresis Disposables
Global apheresis market segmentation, by technology:
- Centrifugation
- Membrane separation
Global apheresis market segmentation, by application:
- Plasmapheresis
- Plateletpheresis
- Erythrocytapheresis
- Leukapheresis
Global apheresis market segmentation, by region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region - North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$ -
- Haemonetics Corporation
- Fresenius Medical Care AG & Co. KGaA
- TERUMO BCT, INC.
- ASAHI KASEI MEDICAL Co., Ltd.
- KAWASUMI LABORATORIES INC.
- Cerus Corporation.
- Braun Melsungen AG
- Hemacare Corporation
- NIKKISO CO., LTD.
-
Request for TOC
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!